Onxeo (EU: ONXEO)

Last close As at 28/03/2024

EUR0.33

−0.01 (−2.94%)

Market capitalisation

EUR37m

Latest Insights

View More

Healthcare | edison tv

Onxeo – Edison Open House interview

Healthcare | edison tv

Onxeo – executive interview

Healthcare | Update

Onxeo — Progress with both REVOCAN and DRIIV-1b trials

Healthcare | Update

Onxeo — Expanding AsiDNA R&D programme

Sector

Healthcare

Balance Sheet

Forecast net debt (€m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 1.7 (3.4) (41.5)
Relative (6.8) (6.6) (38.8)
52 week high/low €0.6/€0.3

Financials

Edison Investment Research is terminating coverage on Steakholder Foods (formerly known as MeaTech) (MITC), Mesoblast (MSB), Bluglass (BLG), InMed Pharmaceuticals (INM), Onxeo (ONXEO), Arcane Crypto (ARCANE) and Aberdeen Diversified Income and Growth Trust (ADIG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (€m) EBITDA (€m) PBT (€m) EPS (fd) (c) P/E (x) P/CF (x)
2019A 4.3 (9.1) (11.5) (14.98) N/A N/A
2020A 1.8 (7.2) (8.2) (12.26) N/A N/A
2021E N/A N/A N/A N/A N/A N/A
2022E N/A N/A N/A N/A N/A N/A

Outlook

Healthcare

Onxeo — Update 6 January 2017

Update

Healthcare

Onxeo — Update 23 August 2016

Update

Healthcare

Onxeo — Update 2 June 2016

Update

Healthcare

Onxeo — Update 21 December 2015